EUVIMEDEUVIMED entdecken
Crossref

Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling

Xue Li, Rui Wang, Xiaonan Ma, Jin Yang, Shen Zhang, Zimeng Zhang, Han Jiang, Jihua Liu, Boyang Yu, Wenling Dai

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04810-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Xue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing…. Hauptthemen laut MEDLINE: Neuralgia, Analgesics, Receptors, N-Methyl-D-Aspartate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: "Double First-Class" University project, Fundamental Research Funds for the Central Universities, Chinese National Natural Science Foundation Youth Fund project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective drugs for neuropathic pain are urgently needed. Natural compound glaucine from Corydalis Rhizoma inhibits spinal sensitization and alleviates neuropathic pain, yet its exact analgesic mechanism remains unclear. A rat model of neuropathic pain was established via chronic constriction injury (CCI) of the sciatic nerve. Behavioral tests (von Frey and Hargreaves tests) were used to assess neuropathic pain symptoms by evaluating mechanical allodynia and thermal hyperalgesia. Primary spinal neurons, glia, and peritoneal macrophages were cultured for in vitro analysis. Molecular pathways were examined using RNA sequencing, Western blot, qRT-PCR, and immunofluorescence. Glaucine significantly suppressed spinal IL-16 expression in CCI rats, and its analgesic effects were reversed by exogenous IL-16 administration. RNA-seq and protein assays confirmed IL-16 upregulation in injured peripheral nerves and spinal cord. Critically, inhibiting IL-16/CD4 signaling at peripheral and spinal levels alleviated neuropathic pain. Dual immunofluorescence in vivo and in vitro revealed IL-16/CD4 localization in neurons, and spinal IL-16 inhibition reduced neuronal activation. Calcium fluorescence imaging further demonstrated that spinal IL-16 blockade reduced spinal neuronal excitability through restraining the NMDA receptor. The IL-16 induced phosphorylation of NMDA receptor was mediated by lymphocyte-specific protein tyrosine kinase (p56lck). Additionally, peripheral macrophages were identified as a source of IL-16 after nerve injury. Glaucine alleviates neuropathic pain by inhibiting the IL-16-p56lck-NMDA axis which promotes pain through enhanced NMDA activity and central sensitization. The targeted inhibition highlights glaucine as a novel therapeutic strategy for alleviating neuropathic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaAnalgesicsReceptors, N-Methyl-D-AspartateAnimalsMaleRats, Sprague-DawleySignal TransductionSpinal CordRatsHyperalgesiaDisease Models, AnimalCells, CulturedSciatic Nerve

Stichwörter der Autor:innen

GlaucineIL-16/CD4NMDARNeuronal excitabilityNeuropathic painP56lck

Substanzen

AnalgesicsReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
  • The Public Laboratory Platform, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
  • Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China. liujihua@cpu.edu.cn.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China. liujihua@cpu.edu.cn.
  • Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu, China. boyangyu59@163.com.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China. boyangyu59@163.com.

Förderung

  • "Double First-Class" University project
  • Fundamental Research Funds for the Central Universities
  • Chinese National Natural Science Foundation Youth Fund project
  • China Postdoctoral Science Foundation program
  • China Postdoctoral Special Funding program
  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Wang, R., Ma, X., Yang, J., Zhang, S., Zhang, Z., Jiang, H., Liu, J., Yu, B., & Dai, W. (2026). Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04810-8

Vancouver

Li X, Wang R, Ma X, Yang J, Zhang S, Zhang Z, et al. Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04810-8

BibTeX
@article{Li2026,
  author = {Li, Xue and Wang, Rui and Ma, Xiaonan and Yang, Jin and Zhang, Shen and Zhang, Zimeng and Jiang, Han and Liu, Jihua and Yu, Boyang and Dai, Wenling},
  title = {Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04810-8}
}
Kostenlos starten →